BridgeMD
New treatment option for Knee Osteoarthristis
Official title Accelerated Rehabilitation in Individuals After Total Knee Arthroplasty
ClinicalTrials.gov ID: NCT07319546
What this study is testing
- What it's testing
- The primary aim of this double-blind randomized controlled trial is to evaluate the effectiveness of an accelerated rehabilitation protocol on knee joint function and quality of life in individuals undergoing TKA compared to conventional rehabilitation in Dali, Yunan, China. The study will include patients aged 50-80 years who are scheduled for primary unilateral TKA.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- Patients diagnosed with end-stage knee OA necessitating primary unilateral TKA.
You likely can't join if
- History of joint infections, cancer, or inflammatory arthritis.
- End-stage OA from rheumatoid or septic arthritis.
- Individuals with neurological disorders such as Alzheimer's disease, - Parkinson's disease, stroke.
- Individuals who are unable to follow a structured rehabilitation protocol.
- Previous history of knee surgeries (other than arthroscopy).
- Severe comorbidities that would hinder participation (e.g., advanced cardiovascular diseases).
See the full eligibility criteria
- Patients diagnosed with end-stage knee OA necessitating primary unilateral TKA.
- History of joint infections, cancer, or inflammatory arthritis.
- End-stage OA from rheumatoid or septic arthritis.
- Individuals with neurological disorders such as Alzheimer's disease, - Parkinson's disease, stroke.
- Individuals who are unable to follow a structured rehabilitation protocol.
- Previous history of knee surgeries (other than arthroscopy).
- Severe comorbidities that would hinder participation (e.g., advanced cardiovascular diseases).
- Individuals who have severe osteoporosis.
The study team makes the final eligibility decision.
Where it's taking place
- Dali, Yunnan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dali, Yunnan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.